Press clippings - Gregory K. Bell

Gregory K. Bell

Group Vice President and Life Sciences Practice Leader
+1-617-425-3357

M&A In The Global Pharmaceuticals Sector 
Financier Worldwide • May 2009
Greg Bell discusses mega mergers between large pharmaceutical companies and the benefits they bring to reduce the proportional impact of patent expirations on revenues and to generate cost savings, among other areas.

Breaking The Cycle; Behind the latest megadeal in pharmaceuticals, a more subtle transformation of the industry is taking place 
Chemical & Engineering News • February 9, 2009
Greg Bell comments about changes taking place in the pharmaceutical industry around research and development, acquisition and new partnerships, and new technologies, among other areas.